Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;122(10):601-4.

Congenital nasal pyriform aperture stenosis: conservative management

Benjamin Collins  1 , Rosser Powitzky, Jessica Enix, G Paul Digoy
Affiliations
  • PMID: 24294681

Congenital nasal pyriform aperture stenosis: conservative management

Benjamin Collins et al. Ann Otol Rhinol Laryngol. 2013 Oct.

Abstract

Objectives: This case series outlines the advantages of using 0.1% intranasal dexamethasone drops (IDD) to treat nasal obstruction in patients with congenital pyriform aperture stenosis (PAS).

Methods: Five consecutive cases of PAS were reviewed.

Results: Three patients were treated with IDD alone, and 2 were treated surgically and had residual postoperative nasal obstruction before IDD. Four patients in follow-up (mean, 1 year) were weaned off the steroid drops with good breathing results. One patient developed iatrogenic Cushing's disease, and another, who was initially treated with surgery, eventually required nasal vestibular stenosis repair in addition to IDD.

Conclusions: This study is the first to review the use of IDD in treating PAS. The potential impact of midnasal stenosis is discussed, and a conservative management algorithm for patients with PAS is presented. Careful surveillance for potential side effects of IDD is recommended, especially in cases that require elevated doses.

PubMed Disclaimer

LinkOut - more resources